Proteoglycans
are one of the major constituents of the extracellular matrix and cell membranes.
In the brain, there are two major proteoglycans, chondroitin sulfate proteoglycans and heparan sulfate proteoglycans.
In 
I. Introduction
Proteoglycans are macromolecules comprising a core protein and sulfated glycosaminoglycan chains, such as chondroitin sulfate and dermatan sulfate (Fig. 1) . They are one of the major constituents of the extracellular matrix and cell membranes of various animal tissues. In the developing nervous tissue, proteoglycans have been suggested to play important roles in various cellular processes such as cell proliferation, neurite formation and signal transduction (reviewed in [27, 28, 36] ). In the adult brain, some proteoglycans exhibit perineuronal localization around a restricted number of neurons and form a net'.
The 'perineuronal net' was first described by Golgi and depicted as a reticular structure covering the cell bodies and proximal dendrites of certain neurons in the adult mammalian central nervous system (reviewed in [13, 14] ). Nerve terminals are thought to connect to the cell surface of neurons through the holes of the perineuronal net.
Although the function of perineuronal proteoglycans are not clear, their distribution around a limited number of neurons implies that they participate in cellular activities specific to the neurons surrounded with proteoglycans.
In this review, we will describe the perineuronal net-constituting proteoglycans, focusing on neurocan. Neurocan is a nervous tissue-unique chondroitin sulfate proteoglycan whose expression and proteolytic cleavage are developmentally regulated [35, 39, 40] . We will also discuss the possible biological significance of the occur- rence of proteoglycans in the perineuronal nets.
II. Proteoglycans in Perineuronal Nets
Immunohistochemical studies revealed that various glycoproteins, proteoglycans and hyaluronic acid are constituents of the perineuronal nets [13, 14] . Table 1 summarizes the proteoglycan species in the perineuronal nets. Proteoglycans have been detected using antibodies which recognize glycosaminoglycan chains or core proteins. Chondroitin sulfates have been shown to be localized in the perineuronal nets using monoclonal antibodies which recognize a stub structure created on the core protein of chondroitin sulfate proteoglycans after chondroitinase ABC treatment [5-7, 12, 23, 33, 43] . Some monoclonal antibodies which recognize specific epitopes on the chondroitin sulfate chains also stained cell surfaces of a subset of neurons [4, 15, 24, 32, 42, 44] . Molecular species of the net-forming chondroitin sulfate proteoglycan have been demonstrated using antibodies which recognize core proteins of these proteoglycans. For example, some aggrecan family members such as versican [9, 12] , aggrecan [3, 12, 19, 20, 22, 23] and neurocan [30] have been shown to form perineuronal nets. In addition, Cat-301 [18, 21] , an aggrecan-related chondroitin sulfate proteoglycan, and some other chondroitin sulfate proteoglycans such as phosphacan [25, 26] , somataglycan-S [46] and DSD-1-PG [47] were also reported to exhibit perineuronal localization.
Although most of the perineuronal net-constituting proteoglycans contain chondroitin sulfate as sulfated Table  1 . Glycosaminoglycans and proteoglycans in perineuronal nets.
polysaccharide chains, Fuxe et al. reported that two monoclonal antibodies specific for heparan sulfate-related epitopes stained neuronal cell surfaces in the rat brain [17] . The mechanisms which tether the perineuronal proteoglycans to the cell surfaces are not clear. Because hyaluronic acid has been shown to be a component of the perineuronal net and to be co-localized with chondroitin sulfate-related materials in the adult rat cerebral cortex [8] , aggrecan family members may attach to cell surface hyaluronic acid through the hyaluronic acid binding domain.
However, Koppe et al. demonstrated that hyaluronidase treatment of rat brain sections did not abolish pericellular staining with anti-chondroitin sulfate antibodies [23] . This result suggests that the proteoglycans are not exclusively bound to hyaluronic acid. In fact, brevican, which is another aggrecan family member, was shown to associate with the cell surfaces of astrocytes through its C-terminal portion which does not include the hyaluronic acid binding domain [49] . However, at present, it is not clear whether brevican forms perineuronal nets as other aggrecan family members do. Because proteoglycans are multi-domain molecules, they may attach to the cell surfaces through more than one domain.
III.
Perineuronal Localization of Neurocan
Multi-domain structure of neurocan Neurocan is a nervous tissue-unique chondroitin sulfate proteoglycan which belongs to the aggrecan family. The cDNA sequence of the neurocan core protein was reported by Rauch et al [39] . The amino acid sequence deduced from the cDNA sequence showed that the neurocan core protein comprises an immunoglobulin domain, a hyaluronic acid-binding domain, a chondroitin sulfate attaching domain, two epidermal growth factor-like domains, a lectin-like domain and a complement regulatory protein-like domain (Fig. 2) . These domains except for the chondroitin sulfate attaching domain show a homology to the corresponding domains of other aggrecan family members, namely aggrecan, versican and brevican.
Developmentally regulated proteolysis of neurocan
One of the interesting features of neurocan is that the proteolytic cleavage of its core protein is developmentally regulated. To detect each neurocan fragment, we raised the two anti-neurocan antibodies shown in Table 2 . A polyclonal antibody, PAb 291, was raised by immunizing a synthetic peptide whose amino acid sequence matched a part of the N-terminal half of neurocan [29] . PAb 291 recognized an N-terminal half fragment of neurocan with a 130 kDa core glycoprotein (designated neurocan-130). A C-terminal half fragment (neurocan-C) was recognized by MAb 1G2 (Fig. 2) [35] .
In the young rat brain, anti-neurocan antibodies Table 2 . The neurocan fragments recognized by two antineurocan antibodies. detect both intact neurocan and some neurocan-derived fragments on Western blot. However, in the adult rat brains, intact neurocan is hardly detectable while the neurocan fragments are observed [29, 31, 35, 40] . Because a riboprobe corresponding to a region of neurocan hybridized with a single band at-7.5 kb on Northern blots of mRNA from 4-day-old and adult rat brain [39] , the neurocan fragments are considered to be products of the proteolytic processing of the intact neurocan but not a product of alternative splicing. Because the core proteins of both neurocan-130 and neurocan-C appeared only after the chondroitinase treatment upon Western blot, they both exist as proteoglycans attaching chondroitin sulfate chains in the brain.
Biological functions of neurocan and its fragments
Neurocan is reported to bind to some cell adhesion molecules such as N-CAM, Ng-CAM/L1 and TAG-1/axonin-1. Through these interactions, neurocan is thought to have a repulsive effect on neurons (for a review, see Ref.
[28]). Retzler et al. have shown that N-CAM binds to all major components of neurocan using various recombinant neurocan fragments [41] . Their results suggest that both neurocan-C and the N-terminal fragments are able to bind to N-CAM.
Therefore, neither the difference in the biological function between the neurocan fragments nor the significance of the cleavage is known at present. However, since the domain structure of the core protein of the C-terminal fragment of neurocan is completely different from that of the N-terminal half fragments, they could have different functions from each other.
The highly conserved amino acid sequences of the cleavage site of rat, mouse and human neurocan (Fig. 2) implies that the production of the neurocan fragments has a certain biological significance.
In addition, two brain-specific hyaluronate binding proteins, GHAP and BEHAB, were found to be the N-terminal fragments of versican and brevican, respectively [37, 48, 50] . There is the possibility that the cleavage of the aggrecan family members may have a common significance.
Distribution of neurocan and its fragments in the developing rat brain
As a first step to determine the functional differences between the neurocan fragments, we compared the localization of the PAb 291 antigen with that of the MAb 1G2 antigen in the cerebral cortex of the developing rat (Table  3) .
Both antigens distributed diffusely in the extracellular matrix in the young brain. The extracellular neurocan may regulate the neurite outgrowth.
In the 29-day-old rat Table 3 . Appearance of the pericellular staining of neurons during the postnatal development of the rat brain. cerebral cortex, PAb 291 stained the surfaces of a small number of cells in addition to the diffuse extracellular staining. In contrast, the MAb 1G2 showed only the diffuse extracellular staining. The pericellular staining with PAb 291 was not found at postnatal day 7 and day 14. Although PAb 291 recognizes both intact neurocan and neurocan-130 in the young rat brain, only neurocan-130 is thought to be localized at the cell surfaces because MAb 1G2, which also recognizes intact neurocan, did not exhibit the pericellular staining.
Distribution of neurocan fragments in the adult rat brain
Because the adult rat brain does not have intact neurocan, immunolabelling with PAb 291 and MAb 1G2 in tissue sections of the adult rat brain could represent the locations of neurocan-130 and neurocan-C, respectively. As shown in Fig. 3 , PAb 291 stained the surfaces of a subset of cells in addition to diffuse staining of the extracellular matrix of adult rat brains. The cerebrum of the adult rat has many more PAb 291-immunopositive cells than the cerebrum at postnatal day 29. In contrast, MAb 1G2 shows only the diffuse extracellular staining. This result suggests that neurocan-130, but not neurocan-C, form perineuronal nets after neurocan is cleaved.
An immunoelectron microscopic study showed that neurocan-130 is localized in the cytoplasm of the glial cell processes (Fig. 4) [30] . Generally speaking, proteoglycans are localized in the extracellular space or at the cell surfaces. Most of the perineuronal net-constituting molecules have also been reported to exist in the extracellular space between the neuronal cell surfaces and the glial processes [10, 13] . However, some CSPGs have been reported to exist intracellularly in adult rat brains although they were not reported to form perineuronal nets [1, 2, 40] . In addition, hyaluronectin, a hyaluronic acid-binding protein, has been reported to exist in the cytoplasm and at the plasma membrane of the glial cell processes [11] . Because neurocan-130, but not neurocan-C, has a hyaluronic acid-binding domain, a supramolecular complex containing neurocan-130, hyaluronic acid and hyaluronectin may present in the cytoplasm of certain glial cell processes.
IV.
Possible Functions of Perineuronal Proteoglycans in the Adult Brain Various investigators have proposed some possible functions of the perineuronal net-constituting molecules.
Because perineuronal nets appear in the vicinity of the synapses relatively late in the neuronal development, the perineuronal net-constituting molecules may be involved in the synapse stabilization or neuronal maturation, as in the case of Cat-301 proteoglycan [18] . Cat-301 proteoglycan is an aggrecan-related chondroitin sulfate proteoglycan whose perineuronal localization is reduced in the dorsal lateral geniculate nucleus of lid-sutured or dark-reared cats.
Additionally or alternatively, the perineuronal nets may reflect some functional heterogeneity of the neurons because only a limited number of neuronal cells are covered with the nets. For example, some chondroitin sulfate proteoglycans, such as Cat-301 proteoglycan, the 473 antigen and DSD-1-PG, often surrounded a subpopulation of GABAergic neurons containing parvalbumin [19, 21, 24, 32, 47] . Sano et al. reported that partly overlapping but different subsets of neurons expressed different glycosaminoglycan epitopes including the 473 antigen [42] . These results suggest that different combinations of perineuronal molecules make heterogeneous microenvironments around different subsets of neurons.
Some chondroitin sulfate proteoglycans could be barriers for neurite elongation.
We reported that a mixture of brain chondroitin sulfate proteoglycans inhibited the neurite outgrowth from PC12D cells [34] . Yamada et al. demonstrated that brevican associates with the surface of glial processes and inhibits neurite outgrowth [49] .
Functions of molecules localized in the cytoplasm of perineuronal glial processes including neurocan-130 are obscure.
The accumulation of certain molecules in a limited number of glial cells may reflect some functional heterogeneity of the glia, such as neurotransmitter uptake and the ability to influence the neuronal morphology [45] .
V. Perspectives
To determine the functions of the proteoglycans in the perineuronal nets, molecules which bind to proteoglycans at the perineuronal site must be elucidated. Because various growth factors are known to bind to heparan sulfate chains [38] , a subset of the growth factors may bind to the chondroitin sulfate chains of the perineuronal proteoglycans. In addition, the characterization of neurons surrounded by the proteoglycans or a discovery of brain diseases which lack perineuronal proteoglycans may help the understanding of their functions.
Destruction of perineuronal nets, as done by Briickner et al. [12] with chondroitinase ABC, may also develop a new strategy to determine the functional significance of the perineuronal nets.
VI.
